Recent APLS Stock Price | APLS Stock Predictions | |
$24.15 | ![]() +83.23% |
$44.25 |
Recent APLS Analyst Ratings Breakdown, Making APLS Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 13 | 13 | 13 | 13 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 8 | 8 | 8 | 8 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.77 | 1.77 | 1.77 | 1.77 |
For the APLS stock predictions from the analysts covering Apellis Pharmaceuticals Inc, we have collected all of the individual APLS stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 20 different analysts covering APLS (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since APLS stock predictions may vary widely, another useful metric to consider is the median APLS stock prediction, which represents the price at which half of the analysts
made APLS stock predictions that were higher and half made APLS stock predictions that were lower. This makes for a different take on the APLS stock predictions out there, as compared to average or mean.
And that median across all the individual APLS stock predictions was: $43.5 as of 2025-03-21.
The very highest of the APLS stock predictions for one year price target was $75.0, while the very lowest of the APLS stock predictions in the analyst group was
$25.0 (with a standard deviation of $14.421). Get the latest Zacks research report on APLS — FREE
Find out: APLS next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
IMTX Stock Predictions
QTT Stock Predictions
CHEF Stock Predictions
ILMN Stock Predictions
INFY Stock Predictions
KB Stock Predictions
RXN Stock Predictions
SNAP Stock Predictions
W Stock Predictions
![]()
![]() |
![]() ![]() |
![]() ![]() |
![]() ![]() |
![]() Buy (3.23 out of 4) 42nd percentile
(ranked lower than approx. 58% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com ![]() |
![]() ![]() |